These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19089675)

  • 21. [Neurogenic diseases of the bladder without urodynamic explanation].
    Schuyten H; Gentens P; Van Camp K
    Acta Urol Belg; 1979 Oct; 47(4):639-42. PubMed ID: 517346
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
    Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
    Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
    Denys P; Phe V; Even A; Chartier-Kastler E
    Ann Phys Rehabil Med; 2014 Jul; 57(5):297-301. PubMed ID: 24958444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuro-muscular dysfunction of the lower urinary tract in multiple sclerosis.
    Van Poppel H; Vereecken RL; Leruitte A
    Paraplegia; 1983 Dec; 21(6):374-9. PubMed ID: 6664687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of neurogenic bladder in multiple sclerosis.
    Piazza DH; Diokno AC
    Urology; 1979 Jul; 14(1):33-5. PubMed ID: 452216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder.
    Tsang B; Stothers L; Macnab A; Lazare D; Nigro M
    Neurourol Urodyn; 2016 Mar; 35(3):354-64. PubMed ID: 25620137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urodynamics and multiple sclerosis.
    Hinson JL; Boone TB
    Urol Clin North Am; 1996 Aug; 23(3):475-81. PubMed ID: 8701560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of bladder problems in patients with multiple sclerosis.
    Unsworth J; Freeman L
    Br J Community Nurs; 2000 May; 5(5):230, 232, 234, 236-8. PubMed ID: 12271205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines in the treatment of neurogenic bladder].
    Vale P
    Acta Med Port; 1999; 12(1-3):119-21. PubMed ID: 10423885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower urinary tract dysfunction due to multiple sclerosis.
    Carr LK
    Can J Urol; 2006 Feb; 13 Suppl 1():2-4. PubMed ID: 16526973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
    Brucker BM; Nitti VW; Kalra S; Herbert J; Sadiq A; Utomo P; Aponte MM
    Neurourol Urodyn; 2017 Apr; 36(4):1208-1213. PubMed ID: 27548624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Ineichen BV; Schneider MP; Hlavica M; Hagenbuch N; Linnebank M; Kessler TM
    Mult Scler; 2018 Apr; 24(4):529-534. PubMed ID: 28367674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vesico-sphincter disorders of nervous origin].
    Amarenco G
    Rev Prat; 1995 Feb; 45(3):331-5. PubMed ID: 7725038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of neurogenic bladder in multiple sclerosis.
    Holland NJ; Wiesel-Levison P; Schwedelson ES
    J Neurosurg Nurs; 1981 Dec; 13(6):337-43. PubMed ID: 6926672
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
    Khavari R; Karmonik C; Shy M; Fletcher S; Boone T
    J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation into neurogenic bladder in arthrogryposis multiplex congenita.
    Arantes de Araújo L; Ferraz de Arruda Musegante A; de Oliveira Damasceno E; Barroso U; Badaro R
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):895-9. PubMed ID: 23491981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OnabotulinumtoxinA and multiple sclerosis.
    Schurch B; Carda S
    Ann Phys Rehabil Med; 2014 Jul; 57(5):302-314. PubMed ID: 24953702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous stimulation of the bladder in multiple sclerosis: a case report.
    Flanigan RC; August HM; Young B; Lucas BA; McRoberts JW
    J Urol; 1983 May; 129(5):1047-8. PubMed ID: 6602224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.